Waqar Haque

2.9k total citations
97 papers, 2.0k citations indexed

About

Waqar Haque is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Waqar Haque has authored 97 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 37 papers in Pulmonary and Respiratory Medicine and 32 papers in Cancer Research. Recurrent topics in Waqar Haque's work include Breast Cancer Treatment Studies (30 papers), Breast Lesions and Carcinomas (22 papers) and Esophageal Cancer Research and Treatment (12 papers). Waqar Haque is often cited by papers focused on Breast Cancer Treatment Studies (30 papers), Breast Lesions and Carcinomas (22 papers) and Esophageal Cancer Research and Treatment (12 papers). Waqar Haque collaborates with scholars based in United States, China and Australia. Waqar Haque's co-authors include Vivek Verma, Bin S. Teh, E. Brian Butler, Sandra S. Hatch, Charles B. Simone, V. Suzanne Klimberg, James W. Welsh, Joe Y. Chang, Tanja Sprave and Charles R. Thomas and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgery.

In The Last Decade

Waqar Haque

93 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Waqar Haque United States 22 939 632 576 427 326 97 2.0k
Sung‐Ja Ahn South Korea 21 512 0.5× 619 1.0× 311 0.5× 273 0.6× 188 0.6× 113 1.5k
Hamouda Boussen Tunisia 21 871 0.9× 290 0.5× 460 0.8× 370 0.9× 343 1.1× 137 1.8k
Carlo Barone Italy 31 2.3k 2.4× 1.4k 2.2× 495 0.9× 671 1.6× 461 1.4× 130 3.6k
Dinesh Chandra Doval India 24 1.2k 1.3× 673 1.1× 428 0.7× 367 0.9× 245 0.8× 101 1.9k
Ellis Levine United States 26 1.1k 1.2× 946 1.5× 664 1.2× 431 1.0× 289 0.9× 92 2.8k
Jerri Linn Phillips United States 19 1.2k 1.3× 1.1k 1.7× 276 0.5× 773 1.8× 144 0.4× 31 2.8k
Zeba Aziz Pakistan 22 1.2k 1.3× 326 0.5× 261 0.5× 269 0.6× 130 0.4× 73 2.0k
Virote Sriuranpong Thailand 21 1.1k 1.1× 381 0.6× 477 0.8× 205 0.5× 220 0.7× 77 2.2k
Maria Carmela Piccirillo Italy 26 1.2k 1.3× 787 1.2× 408 0.7× 223 0.5× 152 0.5× 94 2.3k
María José Bento Portugal 20 979 1.0× 599 0.9× 326 0.6× 447 1.0× 400 1.2× 79 1.8k

Countries citing papers authored by Waqar Haque

Since Specialization
Citations

This map shows the geographic impact of Waqar Haque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waqar Haque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waqar Haque more than expected).

Fields of papers citing papers by Waqar Haque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Waqar Haque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waqar Haque. The network helps show where Waqar Haque may publish in the future.

Co-authorship network of co-authors of Waqar Haque

This figure shows the co-authorship network connecting the top 25 collaborators of Waqar Haque. A scholar is included among the top collaborators of Waqar Haque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Waqar Haque. Waqar Haque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haider, Adawiya J., et al.. (2025). Evaluating the Impact of Adjuvant Radiation Therapy on Survival in Early Stage HER2-Positive Invasive Breast Carcinoma Following Breast-Conserving Surgery. International Journal of Radiation Oncology*Biology*Physics. 123(1). e418–e419.
3.
Haque, Waqar, et al.. (2021). Prognostic and predictive impact of MGMT promoter methylation in grade 3 gliomas. Journal of Clinical Neuroscience. 85. 115–121. 13 indexed citations
4.
Chiang, Stephen, Andrew Farach, Waqar Haque, et al.. (2021). DMSA-SPECT: A Novel Approach to Nephron Sparing SBRT for Renal Cell Carcinoma. Advances in Radiation Oncology. 6(6). 100719–100719. 4 indexed citations
5.
Lewis, Gary D., Yan Xing, Waqar Haque, et al.. (2019). The impact of molecular status on survival outcomes for invasive micropapillary carcinoma of the breast. The Breast Journal. 25(6). 1171–1176. 20 indexed citations
6.
Haque, Waqar, Vivek Verma, E. Brian Butler, & Bin S. Teh. (2019). Patterns of End-of-Life Oncologic Care for Stage IV Non-small Cell Lung Cancer in the United States. Anticancer Research. 39(6). 3137–3140. 8 indexed citations
7.
Verma, Vivek, Amy C. Moreno, Waqar Haque, Penny Fang, & Steven H. Lin. (2018). Sequential Versus Concurrent Chemoradiation Therapy by Surgical Margin Status in Resected Non–Small Cell Lung Cancer. Journal of the National Comprehensive Cancer Network. 16(5). 508–516. 13 indexed citations
8.
Haque, Waqar, et al.. (2018). Outcomes of pleomorphic lobular carcinoma versus invasive lobular carcinoma. The Breast. 43. 67–73. 18 indexed citations
9.
Haque, Waqar, Vivek Verma, Sandra S. Hatch, et al.. (2018). Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy. Breast Cancer Research and Treatment. 170(3). 559–567. 216 indexed citations
10.
Haque, Waqar, Vivek Verma, E. Brian Butler, & Bin S. Teh. (2018). Trends and disparities in the utilization of hypofractionated neoadjuvant radiation therapy for rectal cancer in the United States. Journal of Gastrointestinal Oncology. 9(4). 601–609. 5 indexed citations
11.
Moreno, Amy C., Waqar Haque, Vivek Verma, Penny Fang, & Steven H. Lin. (2018). Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base. Annals of Surgical Oncology. 25(5). 1245–1253. 15 indexed citations
12.
Haque, Waqar, Vivek Verma, E. Brian Butler, Bin S. Teh, & Chad G. Rusthoven. (2018). Post-treatment mortality after definitive chemoradiotherapy versus trimodality therapy for locally advanced non-small cell lung cancer. Lung Cancer. 127. 76–83. 8 indexed citations
13.
Haque, Waqar, Vivek Verma, Andrew Farach, E. Brian Butler, & Bin S. Teh. (2018). Postmastectomy radiation therapy for triple negative, node-negative breast cancer. Radiotherapy and Oncology. 132. 48–54. 11 indexed citations
14.
Haque, Waqar, Vivek Verma, E. Brian Butler, et al.. (2017). Radiation therapy utilization and outcomes for older women with breast cancer: Impact of molecular subtype and tumor grade. The Breast. 35. 34–41. 14 indexed citations
15.
Haque, Waqar, Vivek Verma, E. Brian Butler, & Bin S. Teh. (2017). Radical Cystectomy Versus Chemoradiation for Muscle-invasive Bladder Cancer: Impact of Treatment Facility and Sociodemographics. Anticancer Research. 37(10). 5603–5608. 27 indexed citations
16.
Haque, Waqar, Vivek Verma, E. Brian Butler, & Bin S. Teh. (2017). Chemotherapy Versus Chemoradiation for Node-Positive Bladder Cancer: Practice Patterns and Outcomes from the National Cancer Data Base. Bladder Cancer. 3(4). 283–291. 22 indexed citations
17.
Haque, Waqar, Vivek Verma, E. Brian Butler, & Bin S. Teh. (2017). National Practice Patterns and Outcomes for T4b Urothelial Cancer of the Bladder. Clinical Genitourinary Cancer. 16(1). 42–49.e1. 28 indexed citations
19.
Haque, Waqar, Awad A. Ahmed, Mary R. Schwartz, et al.. (2016). Prognostic Factors, Treatment, and Outcomes in Early Stage, Invasive Papillary Breast Cancer. American Journal of Clinical Oncology. 41(6). 532–537. 7 indexed citations
20.
Rahmatullah, Mohammed, et al.. (2010). A survey of medicinal plants used by kavirajes of chalna area, Khulna district, Bangladesh. African Journal of Traditional Complementary and Alternative Medicines. 7(2). 91–7. 181 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026